Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis. - Wikidata - wikimedia - TriplyDB

Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.

Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.

http://www.wikidata.org/entity/Q37659341

about

Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis

P2860

Q45288114-2DF87734-3AA0-4CEA-8284-37BEAE554023 Q58775742-AF59986E-72B1-475C-B860-00E9C22E055E

P2860

Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.

http://www.wikidata.org/entity/Q37659341

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Chromenopyrazole, a Versatile ...... a Model of Multiple Sclerosis.

@en

Chromenopyrazole, a Versatile ...... a Model of Multiple Sclerosis.

@nl

type

label

Chromenopyrazole, a Versatile ...... a Model of Multiple Sclerosis.

@en

Chromenopyrazole, a Versatile ...... a Model of Multiple Sclerosis.

@nl

prefLabel

Chromenopyrazole, a Versatile ...... a Model of Multiple Sclerosis.

@en

Chromenopyrazole, a Versatile ...... a Model of Multiple Sclerosis.

@nl

P1433

Q37659341-7E1C8ED9-C797-457C-A17D-25FA1237A4C9

P1476

Q37659341-98255E48-DC60-4892-98FA-C1E96268AA2C

P2093

Q37659341-48E77F0E-5ECF-4065-99CB-C8A396F7147B

Q37659341-617BD6AB-A225-4604-A3FD-7FC58913D76C

Q37659341-6E62C423-F298-4BCF-8F58-FCED8A4EC7F3

Q37659341-7D501539-967B-4614-9F18-342E1182FD40

Q37659341-929F8211-AE5C-40B8-9066-CFF3EE26E404

Q37659341-9E4FD5F2-AD6A-415C-8FF4-CB7202D1A8A1

Q37659341-AEC45BCF-BFE9-4A91-BFC7-1706E9FD9E1D

Q37659341-B1B292B1-B864-458B-A1CD-B2F391A0F5E4

Q37659341-EE12F16C-4FC8-4F19-8033-CE418A82293F

P2860

Q37659341-0101AC99-FD36-4976-B3EE-D93F7146726D

Q37659341-02928B2A-FF15-4DD1-B0E7-84D93C4CE5A3

Q37659341-05827C40-A2BC-4D71-AC96-7DA67E777123

Q37659341-0A5652F8-90A1-433B-A071-929C86C198B7

Q37659341-0FA711D8-CF69-42B3-A274-90BA96D27607

Q37659341-185711D3-9B49-4FA3-9481-30339D0DC7CE

Q37659341-1997D20A-69BE-4BAB-9FB7-09214FD36F71

Q37659341-2599FBEB-2146-4F16-B8FA-5D270A0C2184

Q37659341-27DAFE56-46D1-46CC-B8CA-144940B5858E

Q37659341-299750E1-A2CD-4E54-98EE-2BA0FECE0532

P304

Q37659341-DE6919A5-20D6-4A0A-9981-FF85077A1899

P31

Q37659341-0083EA52-3C69-41FB-B5A9-10F4E8C8D787

P356

Q37659341-F37B00B5-2B69-4D6B-A962-C74150330875

P407

Q37659341-564F6C1B-181A-4DAE-86A9-8D4AF17EC8F0

P433

Q37659341-76B72EA1-8B47-48C0-A939-A2BB5C2130C7

P478

Q37659341-072CFDDC-BF36-41DD-9E9E-1B72D572742E

P50

Q37659341-58282F4D-9082-4D28-8461-DC1C76ACBB9B

Q37659341-87DC8B68-3162-412B-9FD6-2D249A300138

Q37659341-98B76F8D-262D-4BD4-AE3A-B3812F0370B7

Q37659341-EBB0B7C3-1521-4E6F-9430-4434369E9A4D

P577

Q37659341-02A24C73-485B-4204-8334-4D757C5DDF4F

P698

Q37659341-C5423323-C061-422C-8130-21D2F15BBE28

P921

Q37659341-11C8967C-D421-4C7C-B992-1DD2D16D5BA2

Q37659341-B91D99AC-B9AB-40E7-829C-E4E6C87AF733

P932

Q37659341-12A121DC-BF02-4F44-9902-4E81118EAE6D

P356

ACS.JMEDCHEM.6B00397

P1433

Journal of Medicinal Chemistry

P1476

Chromenopyrazole, a Versatile ...... a Model of Multiple Sclerosis.

@en

P2093

Carmen Guaza

http://www.w3.org/2001/XMLSchema#string

Dow P Hurst

http://www.w3.org/2001/XMLSchema#string

Gemma Navarro

http://www.w3.org/2001/XMLSchema#string

Javier Fernández-Ruiz

http://www.w3.org/2001/XMLSchema#string

Laura Lagartera

http://www.w3.org/2001/XMLSchema#string

María Gómez-Cañas

http://www.w3.org/2001/XMLSchema#string

Patricia H Reggio

http://www.w3.org/2001/XMLSchema#string

Pilar Goya

http://www.w3.org/2001/XMLSchema#string

Ruth Pazos

http://www.w3.org/2001/XMLSchema#string

P2860

Peripheral cannabinoid receptor, CB2, regulates bone mass.

CB2 receptor-mediated migration of immune cells: it can go either way

Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulation

Crystal structure of rhodopsin: A G protein-coupled receptor

Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Identification and functional characterization of brainstem cannabinoid CB2 receptors

Molecular characterization of a peripheral receptor for cannabinoids

Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

P304

6753-6771

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.JMEDCHEM.6B00397

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Nadine Jagerovic

Francisco Carrillo-Salinas

P577

2016-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27309150

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

5321205

http://www.w3.org/2001/XMLSchema#string